Pfizer ordered to pay $4M in Prempro suit; Is pharma's DTC tax break in danger again?;

 @FiercePharma: Will lame-duck Congress go after pharma's advertising deduction? Ad lobbyists keeping an eye--AdAgeMore | Follow @FiercePharma

> Pfizer ($PFE) was ordered to pay at least $4 million in damages after a jury decided that the Prempro menopause treatment caused a plaintiff's breast cancer. Story

> Advertising lobbyists worry that pharma's tax deduction for direct-to-consumer advertising will evaporate in Congress after the presidential election. Item

> Delaware managed to obtain a scarce sedative used in executions, thanks to a state officials' connections to the drug industry, the Associated Press reports. Article

> If Watson Pharmaceuticals ($WPI) does buy Swiss-based Actavis Group, Deutsche Bank is planning to book a loss of up to €400 million ($528 million). More

> The Canadian province of Ontario plans to cut prices paid for popular generic drugs to 20% of the branded-drug price, to help balance its budget. Report

> Ipsen ($IPSEY) will formally open its new U.S. headquarters in New Jersey this week, after leapfrogging two time zones from the San Francisco area to ease communications with its Paris base. News

> Shanghai Fosun Pharmaceutical won Chinese approval for its IPO in Hong Kong, from which it aims to raise $700 million to $800 million. Story

> X-Rock Industries recalled its over-the-counter sexual supplement for men after the FDA found the active ingredient of Viagra in the product. Item

Biotech News

 @FierceBiotech: Survey: Pharma lags peers in gaining trust via social media. Article | Follow @FierceBiotech

 @JohnCFierce: Biota (Australia) to merge into U.S. biotech Nabi and move to U.S. Release | Follow @JohnCFierce

 @RyanMFierce: Nice visualization of biotech VC trends dating back to '95. Graphics | Follow @RyanMFierce

> AstraZeneca reels in promising PhIII gout drug in $1.26B Ardea buyout. More

> Biotech VC deals, dollars shrivel in Q1 as devices see an upturn. Report

> Pike picked to sit at Quintiles peak. Item

Medical Devices News

 @FierceMedDev: Nephros taps John Houghton as president, CEO. Release | Follow @FierceMedDev

> Spurned by Illumina, Roche may be eyeing universities for gene-sequencing tech. Story

> Singapore streamlines fees, approval times for low-risk devices. Article

> FDA trashes European regulatory process. More

Biotech IT News

> NextBio moves genetic analysis software into clinical R&D territory. News

> Survey: Pharma lags peers in gaining trust via social media. More

> GAO report: FDA's IT modernization 'in jeopardy,' Story

> Google VC fuels Series A round for pharma software startup. Article

And Finally... Despite previous research, a new study found that statin use did not cut the risk of melanoma. Report